Imidazo-pyridine derivatives as activin-like receptor kinase (ALK4 or ALK5) inhibitors

Compounds of formula (I): in free or salt or solvate form, where X, R1, R2, R3 and R4 have the meanings as indicated in the specification, are useful for treating diseases mediated by the ALK-5 and/or ALK-4 receptor. Pharmaceutical compositions that contain the compounds and processes for preparing...

Full description

Saved in:
Bibliographic Details
Main Authors NIKOLAUS JOHANNES STIEFL, CATHERINE LEBLANC, DUNCAN SHAW, CATHY RITCHIE
Format Patent
LanguageEnglish
Published 05.11.2009
Subjects
Online AccessGet full text

Cover

Loading…